J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal By Reuters Stocks January 13, 2025 By Bhanvi Satija and Puyaan Singh (Reuters) -Johnson & Johnson said on Monday it would buy neurological drugmaker Intra-Cellular Therapies…